首页 › 乳腺癌 › 康涅狄格州 › Bridgeport
Bridgeport CT 乳腺癌临床试验
21项针对 乳腺癌的研究正在 Bridgeport及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Stony Brook University Medical Center, Stony Brook · 距离 18 英里
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
招募中3 期
- Stony Brook University-Cancer Center ( Site 0034), Stony Brook · 距离 18 英里
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
招募中3 期
- Research Site, Stony Brook · 距离 18 英里
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
招募中3 期
- Smilow Cancer Hospital Care Center - Trumbull, Trumbull · 距离 4 英里
- Smilow Cancer Hospital Care Center - Fairfield, Fairfield · 距离 5 英里
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
招募中
- Stony Brook Cancer Center, Stony Brook · 距离 18 英里
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
招募中1/2 期
- Stony Brook University Hospital, Stony Brook · 距离 18 英里
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
招募中3 期
- Stony Brook University Medical Center, Stony Brook · 距离 18 英里
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
招募中3 期
- Stony Brook University Cancer Center, Stony Brook · 距离 18 英里
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
招募中3 期
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C. (Port Jefferson Station2), Port Jefferson Station · 距离 19 英里
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C.(Port Jefferson Station1), Port Jefferson Station · 距离 19 英里
- New York Cancers & Blood Specialists, Port Jefferson Station · 距离 19 英里
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
招募中3 期
- Hartford HealthCare - Saint Vincent's Medical Center, Bridgeport
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 距离 4 英里
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 距离 5 英里
- 以及另外 1 项
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
招募中2 期
- Stony Brook Cancer Center, Stony Brook · 距离 18 英里
ATEMPT 2.0: Adjuvant T-DM1 vs TH
招募中2 期
- Smilow Cancer Hospital Care center at Trumbull, Trumbull · 距离 4 英里
- Smilow Cancer Hospital Care center at Fairfield, Fairfield · 距离 5 英里
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
招募中1 期
- New York Cancer and Blood Specialists, Port Jefferson Station · 距离 19 英里
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
招募中3 期
- Stony Brook University Cancer Center, Stony Brook · 距离 18 英里
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
招募中3 期
- Smilow Cancer Hospital - Fairfield, Fairfield · 距离 5 英里
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
招募中3 期
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 距离 4 英里
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 距离 5 英里
- Stony Brook University Medical Center, Stony Brook · 距离 18 英里
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
招募中观察性研究
- Stony Brook Medicine, Stony Brook · 距离 18 英里
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
招募中早期 I 期
- Stony Brook Breast Center, Stony Brook · 距离 18 英里
Definitive Radiation Therapy for Inoperable Breast Cancer
招募中
- Stony Brook University Cancer Center, Stony Brook · 距离 18 英里
Definitive Radiation for High-Risk Spine Metastases
招募中2 期
- Stony Brook University Hospital, Stony Brook · 距离 18 英里
CtDNA Based MRD Testing for NAC Monitoring in TNBC
招募中观察性研究
- Stony Brook University Cancer Center, Stony Brook · 距离 18 英里
其他城市的 乳腺癌试验
- New York City, NY136 项研究
- Houston, TX126 项研究
- Boston, MA112 项研究
- Nashville, TN81 项研究
- Los Angeles, CA73 项研究
- Edison, NJ68 项研究
- St. Louis, MO64 项研究
- Queens, NY64 项研究
- Durham, NC64 项研究
- Chicago, IL59 项研究
- Philadelphia, PA56 项研究
- Dallas, TX55 项研究
Bridgeport的其他研究
- 非小细胞肺癌14 项研究
- 肺癌13 项研究
- 急性髓系白血病12 项研究
- 心血管疾病9 项研究
- 癌症（所有类型）8 项研究
- 头颈鳞状细胞癌8 项研究
- 转移性癌症7 项研究
- 心力衰竭7 项研究
- 脑动脉瘤6 项研究
- 多发性骨髓瘤6 项研究
- 前列腺癌6 项研究
- 卵巢癌5 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。